Full-Time

Medical Science Liaison

Confirmed live in the last 24 hours

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$138.7k - $173.4kAnnually

+ Bonus + Equity Awards

Mid

Remote in USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
PowerPoint/Keynote/Slides
Requirements
  • PharmD or PhD in a related field required.
  • Targeting 5 years of progressively-responsible experience in the biopharmaceutical industry, including 3 years of experience as a field-based MSL.
  • Psychiatry or neurology experience strongly preferred.
  • Scientific, clinical and therapeutic area expertise.
  • Knowledge of regulatory, compliance, commercial, and clinical issues affecting the pharmaceutical and managed care industries.
  • Skilled as a poised and knowledgeable presenter of scientific information.
  • Excellent writing capabilities and strong demonstrated presentation skills, including presentations within external formats such as physician gatherings, medical congresses, etc.
  • Experience in preparation of materials for use by Medical Affairs, including reviewing/editing Promotional materials.
  • Knowledge of customer segments and market dynamics.
  • Excellent planning and organizational skills.
  • Ability to professionally collaboratively interact with all levels within the organization.
  • Skilled at negotiating with business partners or management and influencing leaders.
  • Ability to work independently and with cross-functional teams.
  • Excellent oral and written communication skills, including presentation and facilitation formats.
  • Demonstrated expertise in drug information communication.
  • Highly skilled and proficient with all MS Suites programs, including Outlook, Word, Excel, and PowerPoint.
  • Ability to travel up to 75% of time, with primary residence within the geographical area or near a major airport.
Responsibilities
  • Identifies and develops relationships with national and regional medical and scientific thought leaders, patient advocacy groups, and centers of excellence consistent with the strategy and objectives of Acadia’s Medical Affairs and Development Departments.
  • Engages national and regional thought leaders to align interests, discuss research and medical information, and participate in scientific exchange and education about current and emerging therapies.
  • Provides Phase 2 / 3b / 4 research trial site support and investigator-initiated research proposal cultivation and facilitation.
  • Develops and maintains scientific, clinical and therapeutic expertise for Acadia’s portfolio.
  • Cross-functionally collaborates, following all compliance guidelines, with regional field leadership partners including, HEOR-Field MSLs, Sales Representatives, Patient Access Leaders, and alike Business Leaders.
  • Provides strategic field insights.
  • Identifies disease concepts and compound characteristics that can be leveraged into product differentiation.
  • Provides appropriate scientific, clinical, and educational support for internal and external clients.
  • Represents the company at specific continuing educational events, programs, medical meetings and conventions.
  • Supports Commercial operations by participating in Speaker and Sales Representative Training.
  • Partners with the internal departments to ensure accurate delivery of medical and scientific information.
  • Other duties as assigned.
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting unmet medical needs in neuroscience, ensuring that their products address significant challenges faced by patients. Their goal is to improve the quality of life for individuals with these disorders while also promoting diversity, equity, and inclusion within their operations.

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's exclusive license with Saniona boosts its drug development portfolio.
  • Health Canada approved Daybue for Rett syndrome, expanding Acadia's market presence.
  • The More to Parkinson's campaign raises awareness and strengthens Acadia's brand.

What critics are saying

  • Increased competition in CNS drugs may impact Acadia's market share.
  • Potential clinical trial delays could affect drug approval timelines.
  • Dependence on partnerships like Biovail may impact R&D and commercialization.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on unmet needs in neuroscience, targeting Parkinson's, schizophrenia, and Rett syndrome.
  • The company has a strong R&D pipeline with four product candidates in development.
  • Acadia's strategic partnerships enhance its research capabilities and market reach.

Help us improve and share your feedback! Did you find this helpful?